GLP1 receptor agonist use was shown to be associated with a reduction in the risk for progression to cirrhosis in patients with MASLD and diabetes, and who started the medication early in the course of their disease, 13 leading the FDA to approve semaglutide for this condition in August 2025
Takeuchi, S., Matsuda, T., Kobayashi, S., Takahashi, T
Once you restart semaglutide after surgical clearance, appetite suppression and metabolic effects typically resume within 1 to 2 weeks, helping you restabilize your weight
The positive results observed in the studies could be due to both an increased mitochondrial fatty acid oxidation (which provides the sperm with more energy) and a reduced cell death in the testicles
The role of visfatin (also known as Nicotinamide Phosphoribosyltransferase or NAMPT) in obesity and MetS is complex
In addition to this, studies have found that remaining active not only greatly helps reduce your mortality risk but also suggests it has an associated increase in your life expectancy by 0.4-6.9 years
